Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E DAVIS

Showing results (281-290 of 597) with videos related to

Pageof 60
Sort By:
Journal of Clinical Medicine|February 15, 2022
Temporal Trends in Renal Replacement Therapy in Community-Based People with or without Type 2 Diabetes: The Fremantle Diabetes StudyWendy A Davis, Aron Chakera, Edward Gregg, et al.
Primary Care Diabetes|June 16, 2014
A comparison of two methods of foot health education: the Fremantle Diabetes Study Phase IIMendel Baba, Jenny Duff, Laurie Foley, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2015
Pharmacokinetics of a novel sublingual spray formulation of the antimalarial drug artemether in African children with malariaSam Salman, Daryl Bendel, Toong C Lee, et al.
Journal of Clinical Medicine|December 23, 2023
The Clinical Relevance of Diabetes Distress versus Major Depression in Type 2 Diabetes: A Latent Class Analysis from the Fremantle Diabetes Study Phase IIWendy A Davis, David G Bruce, Timothy M E Davis, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1984
Perfluorocarbon emulsions in cancer therapy: preliminary observations on presently available formulationsR L Goodman, R E Moore, M E Davis, et al.
Diabetologia|September 3, 2025
The relationship between shrunken pore syndrome/selective glomerular hypofiltration syndromes and all-cause mortality in the Fremantle Diabetes Study Phase II. Reply to Gu X, Wei Y [letter]David G Bruce, Wendy A Davis, S A Paul Chubb, et al.
The Medical Journal of Australia|April 6, 2006
Glycaemic levels triggering intensification of therapy in type 2 diabetes in the community: the Fremantle Diabetes StudyTimothy M E Davis, Wendy A Davis Cyllene Uwa Edu Au, David G Bruce
Diabetologia|April 21, 2025
The relationship between shrunken pore syndrome and all-cause mortality in people with type 2 diabetes and normal renal function: the Fremantle Diabetes Study Phase IIDavid G Bruce, Wendy A Davis, S A Paul Chubb, et al.
Tropical Medicine & International Health : TM & IH|October 16, 2014
Accuracy of cerebrospinal leucocyte count, protein and culture for the diagnosis of acute bacterial meningitis: a comparative study using Bayesian latent class analysisLaurens Manning, Moses Laman, Trevor Mare, et al.
Animal : an International Journal of Animal Bioscience|April 18, 2014
Differential expression of cyclin G2, cyclin-dependent kinase inhibitor 2C and peripheral myelin protein 22 genes during adipogenesisJ Zhang, Y Suh, Y M Choi, et al.
Pageof 60

Showing results (281-290 of 597) with videos related to

Sort By:
Pageof 60
Journal of Clinical Medicine|February 15, 2022
Temporal Trends in Renal Replacement Therapy in Community-Based People with or without Type 2 Diabetes: The Fremantle Diabetes StudyWendy A Davis, Aron Chakera, Edward Gregg, et al.
Primary Care Diabetes|June 16, 2014
A comparison of two methods of foot health education: the Fremantle Diabetes Study Phase IIMendel Baba, Jenny Duff, Laurie Foley, et al.
Antimicrobial Agents and Chemotherapy|March 25, 2015
Pharmacokinetics of a novel sublingual spray formulation of the antimalarial drug artemether in African children with malariaSam Salman, Daryl Bendel, Toong C Lee, et al.
Journal of Clinical Medicine|December 23, 2023
The Clinical Relevance of Diabetes Distress versus Major Depression in Type 2 Diabetes: A Latent Class Analysis from the Fremantle Diabetes Study Phase IIWendy A Davis, David G Bruce, Timothy M E Davis, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1984
Perfluorocarbon emulsions in cancer therapy: preliminary observations on presently available formulationsR L Goodman, R E Moore, M E Davis, et al.
Diabetologia|September 3, 2025
The relationship between shrunken pore syndrome/selective glomerular hypofiltration syndromes and all-cause mortality in the Fremantle Diabetes Study Phase II. Reply to Gu X, Wei Y [letter]David G Bruce, Wendy A Davis, S A Paul Chubb, et al.
The Medical Journal of Australia|April 6, 2006
Glycaemic levels triggering intensification of therapy in type 2 diabetes in the community: the Fremantle Diabetes StudyTimothy M E Davis, Wendy A Davis Cyllene Uwa Edu Au, David G Bruce
Diabetologia|April 21, 2025
The relationship between shrunken pore syndrome and all-cause mortality in people with type 2 diabetes and normal renal function: the Fremantle Diabetes Study Phase IIDavid G Bruce, Wendy A Davis, S A Paul Chubb, et al.
Tropical Medicine & International Health : TM & IH|October 16, 2014
Accuracy of cerebrospinal leucocyte count, protein and culture for the diagnosis of acute bacterial meningitis: a comparative study using Bayesian latent class analysisLaurens Manning, Moses Laman, Trevor Mare, et al.
Animal : an International Journal of Animal Bioscience|April 18, 2014
Differential expression of cyclin G2, cyclin-dependent kinase inhibitor 2C and peripheral myelin protein 22 genes during adipogenesisJ Zhang, Y Suh, Y M Choi, et al.
Pageof 60